Clinical Trials Logo

Aortic Valve Disease Mixed clinical trials

View clinical trials related to Aortic Valve Disease Mixed.

Filter by:
  • None
  • Page 1

NCT ID: NCT06455787 Not yet recruiting - Clinical trials for Aortic Valve Regurgitation

J-Valve Transfemoral Pivotal Study

JOURNEY
Start date: July 2024
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the safety and efficacy of the J-Valve Transfemoral (TF) System in patients with symptomatic, severe (grade 3 or 4), native aortic valve regurgitation (AR) and AR-dominant mixed aortic valve disease, who are judged by a multi-disciplinary heart team to be at high risk for open surgical aortic valve replacement (SAVR).

NCT ID: NCT06257043 Recruiting - Clinical trials for Aortic Valve Disease Mixed

Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients

Start date: October 30, 2023
Phase:
Study type: Observational [Patient Registry]

The purpose of this prospective multi-center, observational registry in China is to collect clinical baseline, procedural, and follow-up data of all patients treated with TAVR in China and to evaluate short-, mid-, and long-term clinical outcome data of all post-marketing transcatheter valves. Each center will collect baseline and procedural data as well as clinical outcomes for up to 10 years.

NCT ID: NCT04149600 Recruiting - Clinical trials for Aortic Valve Disease

Identification of Genetic Causes of Calcific Aortic Valve Disease

Start date: September 25, 2018
Phase:
Study type: Observational

This study aims to identify the molecular genetic causes of the variability in development of calcific aortic valve disease in bicuspid and tricuspid aortic valves and their associated aortic dilation.

NCT ID: NCT01368250 Recruiting - Clinical trials for Aortic Valve Disease Mixed

SwissTAVI Registry

Start date: February 2011
Phase:
Study type: Observational

The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.